Paper
6 December 2022 Clinical effect of Huoxue Tongluo Qingnao decoction on transient ischemic attack vertigo
Yanyong Miao, Xiaolei Han, Liuyang Meng
Author Affiliations +
Proceedings Volume 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022); 1245821 (2022) https://doi.org/10.1117/12.2660660
Event: International Conference on Biomedical and Intelligent Systems, 2022, Chengdu, China
Abstract
Objective: To observe the effect of Huoxue Tongluo Qingnao Decoction in the treatment of patients with transient cerebral ischemic attack vertigo. Methods: The author selected 60 patients with transient cerebral ischemic attack vertigo. The patients in the observation group were treated with Huoxue Tongluo Qingnao Decoction combined with conventional treatment, and the patients in the control group were treated with conventional treatment. Results: Compared with the patients in the control group, it can be concluded that the clinical total effective rate, the score of vertigo symptoms after treatment, and the score of apoplexy symptoms after treatment in the observation group were significantly improved, P<0.05; Aura symptom score, P>0.05. Conclusion: Huoxue Tongluo Qingnao Decoction is used in the treatment of transient cerebral ischemic attack vertigo, and the effect is ideal.
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yanyong Miao, Xiaolei Han, and Liuyang Meng "Clinical effect of Huoxue Tongluo Qingnao decoction on transient ischemic attack vertigo", Proc. SPIE 12458, International Conference on Biomedical and Intelligent Systems (IC-BIS 2022), 1245821 (6 December 2022); https://doi.org/10.1117/12.2660660
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Blood

Heart

Medicine

Diagnostics

Kidney

Liver

Magnetic resonance imaging

Back to Top